Q1 2019 13F Holders as of 31 Mar 2019
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
80,437,135
-
Number of holders
-
169
-
Total 13F shares, excl. options
-
58,617,454
-
Shares change
-
+9,838,933
-
Total reported value, excl. options
-
$2,206,343,369
-
Value change
-
+$373,569,818
-
Put/Call ratio
-
82%
-
Number of buys
-
106
-
Number of sells
-
-53
-
Price
-
$37.64
Significant Holders of PTC THERAPEUTICS, INC. - Common Stock (PTCT) as of Q1 2019
208 filings reported holding PTCT - PTC THERAPEUTICS, INC. - Common Stock as of Q1 2019.
PTC THERAPEUTICS, INC. - Common Stock (PTCT) has 169 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 58,617,454 shares
of 80,437,135 outstanding shares and own 73% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (4,968,189 shares), BlackRock Inc. (4,107,898 shares), FRANKLIN RESOURCES INC (3,744,376 shares), PRICE T ROWE ASSOCIATES INC /MD/ (3,524,542 shares), Point72 Asset Management, L.P. (2,905,393 shares), RTW INVESTMENTS, LP (2,514,271 shares), STATE STREET CORP (2,500,926 shares), FMR LLC (2,436,735 shares), SCOPIA CAPITAL MANAGEMENT LP (2,106,190 shares), and CITADEL ADVISORS LLC (2,092,195 shares).
This table shows the top 169 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.